TALPHERA, INC.

TLPH · Nasdaq · SIC 2834: Pharmaceutical Preparations
352
SEC Filings

Business Summary

PART I Overview We are a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Our Portfolio Our portfolio is principally focused on our lead product candidate, Niyad (nafamostat mesylate), for use as a regional anticoagulant during continuous renal replacement therapy, or CRRT. In addition, we may develop LTX-608, a nafamostat formulation for direct IV infusion for one or more of the following indicati...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTLPHdiscussed_in_filing Cybersecurity
topic_mentionTLPHdiscussed_in_filing Trusted Computing
topic_mentionTLPHdiscussed_in_filing Blockchain & Crypto
topic_mentionTLPHdiscussed_in_filing Capital Expenditure
topic_mentionTLPHdiscussed_in_filing Supply Chain
topic_mentionTLPHdiscussed_in_filing Regulation
topic_mentionTLPHdiscussed_in_filing Healthcare & Bio
topic_mentionTLPHdiscussed_in_filing Cybersecurity
topic_mentionTLPHdiscussed_in_filing Trusted Computing
topic_mentionTLPHdiscussed_in_filing Blockchain & Crypto
topic_mentionTLPHdiscussed_in_filing Capital Expenditure
topic_mentionTLPHdiscussed_in_filing Supply Chain
topic_mentionTLPHdiscussed_in_filing Regulation
topic_mentionTLPHdiscussed_in_filing Healthcare & Bio
topic_mentionTLPHdiscussed_in_filing Cybersecurity
topic_mentionTLPHdiscussed_in_filing Trusted Computing
topic_mentionTLPHdiscussed_in_filing Blockchain & Crypto
topic_mentionTLPHdiscussed_in_filing Capital Expenditure
topic_mentionTLPHdiscussed_in_filing Supply Chain
topic_mentionTLPHdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001437749-26-009387EDGAR66K words
2025-03-312024-12-310001437749-25-010250EDGAR—
2024-03-062023-12-310001437749-24-006849EDGAR—
2023-03-312022-12-310001437749-23-008737EDGAR—
2022-03-102021-12-310001437749-22-005888EDGAR—
2021-03-152020-12-310001437749-21-006074EDGAR—
2020-03-162019-12-310001437749-20-005304EDGAR—
2019-03-072018-12-310001437749-19-004353EDGAR—
2018-03-092017-12-310001437749-18-004222EDGAR—
2017-03-032016-12-310001437749-17-003702EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001437749-25-034499EDGAR42K words
2025-08-142025-06-300001437749-25-027002EDGAR—
2025-05-142025-03-310001437749-25-016898EDGAR—
2024-11-132024-09-300001437749-24-034965EDGAR—
2024-08-142024-06-300001437749-24-026801EDGAR—
2024-05-142024-03-310001437749-24-016694EDGAR—
2023-11-142023-09-300001437749-23-031742EDGAR—
2023-08-102023-06-300001437749-23-023124EDGAR—
2023-05-102023-03-310001437749-23-013658EDGAR—
2022-11-142022-09-300001437749-22-027307EDGAR—
2022-08-112022-06-300001437749-22-020168EDGAR—
2022-05-162022-03-310001437749-22-012491EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-230001437749-26-009299EDGAR3K words
2026-03-160001437749-26-008318EDGAR—
2026-03-130001437749-26-008217EDGAR—
2025-11-120001437749-25-034446EDGAR—
2025-10-240001437749-25-031731EDGAR—
2025-10-220001437749-25-031468EDGAR—
2025-10-160001437749-25-031162EDGAR—
2025-09-100001437749-25-028787EDGAR—
2025-08-140001437749-25-026938EDGAR—
2025-06-050001437749-25-019574EDGAR—

352 total filings indexed. 320 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001427925
TickerTLPH
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b80aeec748f14ffef73aa9656cdde503eec77b5d3b973409e8882a22291c2eb3
parent: 2b923393d14b9ca5d81c44c3c1428802f79062ea9e7828625ff57b3d476d3d11
content hash: f1f6886b9dcd2ba6ad09fb409c46ede9ecac70fcc0e8bcbfe2e8b363d007636c
signed: 2026-04-13T04:47:49.188Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf